RHOB and colorectal cancer: In some studies, RhoB exhibits oncogenic properties by promoting cell proliferation and growth, and reducing therapy response, resulting in poor clinical outcomes including primary tumor metastasis and short survival of patients including colorectal cancers [14, 29, 30].